Affiliation:
1. Boston University Henry M. Goldman School of Dental Medicine , 100 East Newton Street , Boston, MA 02118-2308 , USA
2. Boston University Henry M. Goldman School of Dental Medicine , Boston, MA , USA
3. University of Detroit Mercy School of Dentistry , Detroit, MI , USA
Abstract
Abstract
Background:
The purpose of this systematic review is to summarize the literature examining associations between salivary biomarkers and cardiovascular disease (CVD) status.
Contents:
An advanced search was conducted using MeSH terms related to salivary biomarkers and CVD, and entered into the PubMed, Web of Science, and Google Scholar search databases. Four hundred and thirty-three records were narrowed to 22 accepted articles. Included titles were assessed for quality using the Newcastle-Ottawa scale, and ranked into categories of low, moderate, or high.
Summary:
A total of 40 salivary biomarkers were analyzed among accepted articles. The most studied markers were salivary creatine kinase isoform MB, C-reactive protein (CRP), matrix metalloproteinase-9, troponin I, myeloperoxidase, myoglobin, and brain natriuretic peptide. Salivary CRP provided the most consistent trends. Statistically significant increases of salivary CRP were present with CVD in every study that analyzed it. The remaining six markers demonstrated varying patterns.
Outlook:
Existing studies provide insufficient data to draw definitive conclusions. Current research shows that there is an association between some salivary biomarkers and CVD, but the details of existing studies are conflicting. Despite inconclusive results, the diagnostic potential of saliva shows promise as a non-invasive means of cardiovascular risk assessment.
Subject
Biochemistry, medical,Clinical Biochemistry,General Medicine
Reference33 articles.
1. Humphrey SP, Williamson RT. A review of saliva: normal composition, flow, and function. J Prosthet Dent 2001;85:162–9.
2. Lee JM, Garon E, Wong DT. Salivary diagnostics. Orthodont Craniofac Res 2009;12:206–11.
3. Cardiovascular Diseases (CVDs). c2017. World Health Organization. 2017. Available at: http://www.who.int/mediacentre/factsheets/fs317/en. Accessed 26 Apr 2017.
4. Floriano PN, Christodoulides N, Miller CS, Ebersole JL, Spertus J, Rose BG, et al. Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study. Clin Chem 2009;55:1530–8.
5. Foley JD, 3rd, Sneed JD, Steinhubl SR, Kolasa JR, Ebersole JL, Lin Y, et al. Salivary biomarkers associated with myocardial necrosis: results from an alcohol septal ablation model. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;114:616–23.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献